| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |